Skye Bioscience Inc (SKYE)

[1990]

In my opinion it's only trading at .17 cents for multiple reason.

1. They hired a firm that screwed them in the past and diluted them unnecessarily. As a result, they have filed a lawsuit and are awaiting results.

2. If you compare share structure to that of NMUS you would see that it would be trading higher than NMUS is

3. Not sure about the specifics about what you mentioned about the patents. But even if there patent gives them access to specific medications that's still powerful and makes a lot of money

4. If this was an American firm I think it would gain more credibility

5. Lack of appreciation for great weed stocks. For example don't you think NMUS should be trading higher? It's not because I think weed stocks still significantly fall under people's radar

6. I think people are awaiting completion of the drug cause it could still fail

Overall there are a lot of reasons why I think OWCP is under valued. I think NMUs has great potential which is why I'm invested but in terms of how far along the companies are OWCP is closer to a big time development in my opinion. But then again like everything with biotechs it can always fall flat.